Financial statements Apteka Avicenna Kowalczyk Adamczyk
Balance sheet data of APTEKA AVICENNA KOWALCZYK ADAMCZYK
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Total assets | 975 907,81 | 978 613,35 | 1 074 080,66 |
A. Fixed assets | 40 188,35 | 14 806,24 | 0,00 |
B. Current assets | 935 719,46 | 963 807,11 | 1 074 080,66 |
C. Share capital contributions (basic funds) | - | - | - |
D. Own shares (stocks) | - | - | - |
Total liabilities | 975 907,81 | 978 613,35 | 1 074 080,66 |
A. Equity | 452 530,00 | 508 834,48 | 449 762,49 |
B. Liabilities and provisions for liabilities | 523 377,81 | 469 778,87 | 624 318,17 |
I. Long-term liabilities | 25 875,00 | 10 317,11 | 0,00 |
II. Short-term liabilities | 438 003,86 | 398 278,82 | 566 997,54 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.